# Novo Nordisk awards Emerson $40M automation contract for new US plant

Novo Nordisk awarded Emerson a $40 million automation systems and services contract for its new $2 billion drug manufacturing facility in Clayton, North Carolina, targeting operational readiness by 2020.

- Type: Contract
- Announced: 2017-11-13
- Where: Clayton, North Carolina, United States
- Value: $40.0M
- Status: announced
- Products: automation systems, DeltaV distributed control system, Syncade
- Sectors: [Industrial Machinery](https://endata.com/sectors/industrial-machinery.md), [Automation and Robotics](https://endata.com/sectors/automation-robotics.md)

## Companies

- [Emerson](https://endata.com/companies/355.md) (supplier)
- [Novo Nordisk](https://endata.com/companies/17868.md) (customer)

## Sources

- [biospace.com](https://www.biospace.com/novo-nordisk-selects-emerson-to-help-bring-medication-to-market-more-quickly-to-address-growing-diabetes-epidemic), 2017-11-13: "Our extensive experience in the life sciences industry and integrated offering for capital projects and automation perfectly positions us to help Novo Nordisk deliver its largest project in history."
- [drugdiscoverytrends.com](https://www.drugdiscoverytrends.com/novo-nordisk-awards-40m-automation-contract-for-new-u-s-manufacturing-facility/), 2017-11-15: "Novo Nordisk has awarded Emerson a $40 million automation systems and services contract for a new U.S.-based drug manufacturing facility to help battle the global diabetes epidemic."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.